HALONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
HALOZYME THERAPEUTICS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$122.50+0.66 (+0.54%)
Close on Oct 19, 2026
- Market cap
- $14.85B
- P/E (TTM)
- 36.1
- Dividend yield
- –
SEC filings
40 of Halozyme Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Sep 28, 2026 | Sep 30, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 22, 2026 | Sep 22, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 17, 2026 | Sep 18, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 16, 2026 | Sep 16, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 14, 2026 | Aug 18, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 6, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 6, 2026 | Aug 6, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 30, 2026 | Jul 2, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 11, 2026 | SEC EDGAR |
| Current report | 8-K | May 11, 2026 | May 11, 2026 | SEC EDGAR |
| Current report | 8-K | May 5, 2026 | May 7, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 30, 2026 | Apr 30, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 22, 2026 | Apr 24, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Dec 31, 2025 | Mar 23, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 12, 2026 | Mar 12, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Feb 17, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 17, 2026 | Feb 17, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 28, 2026 | Jan 28, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 4, 2025 | Dec 9, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 4, 2025 | Dec 8, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 18, 2025 | Nov 24, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 6, 2025 | Nov 12, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 6, 2025 | Nov 7, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 5, 2025 | Nov 5, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 3, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 3, 2025 | Nov 3, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 14, 2025 | Oct 14, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 1, 2025 | Oct 6, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 30, 2025 | Oct 3, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 30, 2025 | Oct 1, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 5, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 5, 2025 | Aug 5, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 6, 2025 | SEC EDGAR |
| Current report | 8-K | May 6, 2025 | May 6, 2025 | SEC EDGAR |
| Current report | 8-K | May 1, 2025 | May 2, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 17, 2025 | Mar 21, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Dec 31, 2024 | Mar 18, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Feb 18, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 18, 2025 | Feb 18, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 11, 2025 | Feb 13, 2025 | SEC EDGAR |